1
Orphan Designations
0 approved, 1 designated
0
FDA Approvals
0
Active Trials
0
Rare Diseases
0
News (30d)
Quiet
Angiocrine Bioscience, Inc. is a company with 1 orphan drug designation across 0 rare diseases.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
No pipeline data available yet.